Other Surgical Applications

Three out of every one hundred people who has surgery will develop a surgical site infection, and the incident rate may be as high as 30% depending on the surgical procedure. Collatamp G has been shown in clinical studies to reduce surgical site infections more than 50%.3 For patients, this means easier recovery times, shorter hospital stays, lower chance of readmission to the hospital, and a decreased risk of death. Collatamp G has been used in over 2 million patients for over 20 years and there have been no reported side effects to date.

Studies showing the efficiency of Collatamp G for general surgery patients